Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $31.4100 (2.21%) ($30.3800 - $32.1300) on Thu. Jun. 25, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.82% (three month average) | RSI | 64 | Latest Price | $31.4100(2.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT advances 10.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(58%) ARKG(56%) IBUY(54%) IWC(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.41% in a week (0% probabilities). VIXM(-29%) UUP(-15%) VXX(-13%) TBT(-6%) IYT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.41% (StdDev 4.82%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $32.37(-2.97%) | 10 Day Moving Average | $31.19(0.71%) | 20 Day Moving Average | $29.19(7.61%) | To recent high | -8.5% | To recent low | 69.8% | Market Cap | $1.951b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |